ReGelTec Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
ReGelTec General Information
Description
Developer of injectable hydrogel technology intended to address chronic lower back pain associated with degenerative disc disease. The company uses a proprietary gel that transitions from liquid to solid within the intervertebral disc to mimic natural disc biomechanics and maintain spinal motion, enabling healthcare providers and patients to access a minimally invasive treatment option aimed at preserving mobility and reducing pain.
Contact Information
Website
www.regeltec.comCorporate Office
- 323 West Camden Street
- Suite 600
- Baltimore, MD 21201
- United States
Corporate Office
- 323 West Camden Street
- Suite 600
- Baltimore, MD 21201
- United States
ReGelTec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 4. Accelerator/Incubator | 06-Jun-2025 | Completed | Clinical Trials - General | |||
| 3. Angel (individual) | 01-Oct-2023 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 15-Oct-2020 | $4M | $6M | Completed | Product Development | |
| 1. Seed Round | 07-Sep-2018 | $2M | $2M | Completed | Startup |
ReGelTec Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ReGelTec Patents
ReGelTec Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10507264-B1 | Cross-linked hydrogels and method of making the same | Active | 07-Jan-2019 | ||
| JP-2022522944-A | Hydrogel and its manufacturing method | Active | 07-Jan-2019 | ||
| JP-7663949-B2 | Hydrogel and method for producing same | Active | 07-Jan-2019 | ||
| AU-2020205635-A1 | Hydrogels and method of making the same | Active | 07-Jan-2019 | ||
| AU-2020205635-B2 | Hydrogels and method of making the same | Active | 07-Jan-2019 | A61L27/52 |
ReGelTec Signals
ReGelTec Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Riptide Ventures | Angel Group | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| PTX Capital | Venture Capital | Minority | ||
| Tech Council Ventures | Venture Capital | Minority |
ReGelTec FAQs
-
When was ReGelTec founded?
ReGelTec was founded in 2018.
-
Where is ReGelTec headquartered?
ReGelTec is headquartered in Baltimore, MD.
-
What is the size of ReGelTec?
ReGelTec has 10 total employees.
-
What industry is ReGelTec in?
ReGelTec’s primary industry is Therapeutic Devices.
-
Is ReGelTec a private or public company?
ReGelTec is a Private company.
-
What is ReGelTec’s current revenue?
The current revenue for ReGelTec is .
-
How much funding has ReGelTec raised over time?
ReGelTec has raised $6M.
-
Who are ReGelTec’s investors?
MedTech Innovator, Riptide Ventures, Keiretsu Forum, PTX Capital, and Tech Council Ventures are 5 of 6 investors who have invested in ReGelTec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process